Navigation Links
Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis
Date:11/23/2009

se, pivotal, phase 3 clinical trial in cystinosis patients. Upon receiving FDA and EMEA concurrence, Raptor intends to initiate its phase 3 clinical trial at multiple sites in the US and Europe in the first quarter of 2010.

DR Cysteamine is Raptor's proprietary, enteric-coated micro-bead formulation of immediate release cysteamine bitartrate capsules, the current standard of care for treating cystinosis.

Bruce Barshop, M.D., Ph.D., Professor of Clinical Pediatrics at UCSD and principal investigator for the cystinosis clinical trial of DR Cysteamine, stated, "The excellent tolerability of DR Cysteamine, as demonstrated in this study, represents a major step forward in potentially improving the treatment of cystinosis. Raptor's formulation has the potential to improve dosing compliance and long-term outcomes for cystinosis patients."

Raptor's phase 2b clinical trial followed earlier clinical trials with an enteric-coated cysteamine prototype conducted by Ranjan Dohil, M.D., Associate Professor of Pediatrics at UCSD and funded by the Cystinosis Research Foundation ("CRF"). The CRF also supported Raptor's phase 2b clinical trial.

Patrice P. Rioux, M.D., Ph.D., chief medical officer of Raptor, said, "The results from our phase 2b trial are consistent with previous clinical findings from Dr. Dohil and support our plans to provide a twice-daily cysteamine therapy for cystinosis patients. We look forward to continuing our development program of DR Cysteamine in cystinosis with a phase 3 clinical trial."

Cystinosis is an inborn metabolic error characterized by the abnormal transport of cystine, an amino acid, out of the lysosomes. Failure to treat cystinosis can cause serious health consequences, including renal failure and resultant kidney transplant, growth failure, rickets, photophobia and blindness. Symptom onset typically occurs within the first year of life, when cystine crystals accumulate in various tissues and
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
2. Merriman Curhan Ford Acted as Financial Advisor to TorreyPines Therapeutics, Inc. in the Completed Merger With Raptor Pharmaceuticals Corp.
3. Raptor Pharmaceutical Expands Board of Directors
4. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
5. Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
6. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
7. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
8. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
9. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
10. Raptor Pharmaceuticals Provides Update on Targeting Platforms
11. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  Diplomat, the nation,s ... David Dreyer to the Board of Directors ... director and will also serve as chair of the ... 30 years of accounting, financial, compliance and operating experience ... Dreyer has served as chief financial officer, chief operating ...
(Date:9/19/2014)... -- Five MinuteClinic walk-in medical clinics are opening inside select CVS/pharmacy ... clinics opened in Memphis and ... added in Springfield on September 24 and ... to open October 22.  MinuteClinic is the largest and fastest growing ... . The Memphis -area clinics ...
(Date:9/19/2014)... , September 19, 2014 ... Equipment Type (Benchtop, Mobile, Industrial, & Laboratory), Industry ... (Tray-style, Manifold, & Rotary) & Geography - Global ... defines and segments the lyophilization market on the ... analyses and projections of the market size of ...
Breaking Medicine Technology:David Dreyer Appointed to Diplomat Board of Directors 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3
... Mindray Medical International Limited (NYSE: MR ... devices worldwide, announced today an agreement to acquire a ... The terms of the agreement were not disclosed as ... Founded in 2003 and based in Suzhou, China, ...
... NEWARK, N.J., July 5, 2011 Regulators are ... punish corporate officers they suspect of wrongdoing—in effect, ... their jobs. It is unclear whether they intend ... dubbed the "death penalty" by some—but at a ...
Cached Medicine Technology:Mindray Medical to Acquire a Controlling Stake in Suzhou Hyssen Electronics 2Mindray Medical to Acquire a Controlling Stake in Suzhou Hyssen Electronics 3Feds Might 'Banish' More Execs for Misconduct, Attorney Says 2Feds Might 'Banish' More Execs for Misconduct, Attorney Says 3
(Date:9/22/2014)... (PRWEB) September 22, 2014 TherapySites ... titled "From Divorce Talk to Solution Talk: Solution Focused ... The 60-minute webinar, presented by special guest speaker Elliott ... 1pm Central Standard Time. , Reserve Your Seat ... Solution Talk: Solution Focused Brief Therapy with the Most ...
(Date:9/22/2014)... The Ruby Report was launched by ... International Conference in Louisville, Kentucky. This release followed the ... a reception attended by 60 people from the local ... had gained while conducting her research, what drove her ... issue, and what she believes companies can do to ...
(Date:9/21/2014)... CA (PRWEB) September 22, 2014 CareSpan ... it has entered into a joint services agreement with ... Dakota, to deploy the CareSpan Virtual Clinic in multiple ... Avera eCARE plan to deploy their joint services in ... and Wyoming where Avera eCARE is licensed. The two ...
(Date:9/21/2014)... September 22, 2014 UNIWIGS, one of the ... extensions and hair pieces, offers a line of human hair ... trend and it also shows people what the latest ... famous star Rihanna, there are 4 different hairstyles to choose ... of ombre wave lace wigs and a hot ombre red ...
(Date:9/21/2014)... September 21, 2014 More than a quarter of ... dryer fires start in one of two ways. The first ... out properly. The second type of dryer fire occurs when ... (Dryers can also catch fire due to malfunctioning electrical systems so ... to take a look!) Here are some ways that you ...
Breaking Medicine News(10 mins):Health News:TherapySites Presents a Webinar, "From Divorce Talk to Solution Talk: Solution Focused Brief Therapy with the Most Trying of Couples Sessions” with Elliott Connie 2Health News:TherapySites Presents a Webinar, "From Divorce Talk to Solution Talk: Solution Focused Brief Therapy with the Most Trying of Couples Sessions” with Elliott Connie 3Health News:Ruby Report Book Launch Reveals Critical Insights on Gender Intelligence 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 2Health News:Avera eCARE and CareSpan form Collaboration to Deliver “Virtualized” Primary Care in the Dakotas and Wyoming 3Health News:UniWigs New Arrivals Just In- Human Hair Lace Wigs Inspired By Famous Celebrities 2Health News:Restoration Local Offers Tips to Avoid Dryer Fires 2Health News:Restoration Local Offers Tips to Avoid Dryer Fires 3
... and more than 300 people in the UK die from ... permanent disabilities. Now researchers will work on a potential vaccine ... medical charity Meningitis UK. , Although vaccines exist to protect ... to protect against all strains, including the most common in ...
... Immediate Moratorium on Bisphenol,A in Baby Bottles, Food and ... Dozens of state,and national environmental health organizations in the ... the use of bisphenol A (BPA) in baby,bottles and ... of a,new study that demonstrates the toxic chemical BPA ...
... intramuscular injection, study says , , THURSDAY, Feb. 7 ... for delivering DNA vaccines than intramuscular injection, a new ... Genetic Vaccines and Therapy , researchers at the ... protein from the human papillomavirus (HPV), which causes cervical ...
... operating results for the fourth quarter and year ended December 31,2007., Fourth ... $6.883 billion. -- Net income totaled $278 million, ... prior year. -- Adjusted EBITDA totaled $1.153 ... in the prior year. -- Provision for doubtful ...
... DURHAM, NC A novel drug designed to lessen muscle ... at the Duke Clinical Research Institute. Results of the study, ... issue of the journal Circulation, reflect the first time the ... known as KAI-9803, blocks the activity of an enzyme called ...
... 7 Anthera Pharmaceuticals,Inc., a privately held biopharmaceutical ... the Phase II trial,of its novel secretory phospholipaseA2 ... disease will be presented as a late breaker,at ... Scientific Session,on Monday, March 31, 2008 in Chicago, ...
Cached Medicine News:Health News:Meningitis vaccine study gets £200,000 boost 2Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 2Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 3Health News:Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study 4Health News:Tattooing Best Way to Deliver DNA Vaccines 2Health News:HCA Reports Fourth Quarter - Year End 2007 Results 2Health News:HCA Reports Fourth Quarter - Year End 2007 Results 3Health News:HCA Reports Fourth Quarter - Year End 2007 Results 4Health News:HCA Reports Fourth Quarter - Year End 2007 Results 5Health News:HCA Reports Fourth Quarter - Year End 2007 Results 6Health News:HCA Reports Fourth Quarter - Year End 2007 Results 7Health News:HCA Reports Fourth Quarter - Year End 2007 Results 8Health News:HCA Reports Fourth Quarter - Year End 2007 Results 9Health News:HCA Reports Fourth Quarter - Year End 2007 Results 10Health News:HCA Reports Fourth Quarter - Year End 2007 Results 11Health News:HCA Reports Fourth Quarter - Year End 2007 Results 12Health News:HCA Reports Fourth Quarter - Year End 2007 Results 13Health News:HCA Reports Fourth Quarter - Year End 2007 Results 14Health News:HCA Reports Fourth Quarter - Year End 2007 Results 15Health News:Novel compound may lessen heart attack damage 2Health News:Data From Anthera's Plasma Trial to be Presented as Late Breaker at American College Of Cardiology Scientific Sessions 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: